Top Markets
Coin of the day
ReNeuron Group plc ReNeuron Group plc

ReNeuron Group plc

RENE
Xếp hạng trong cổ phiếu #41656
Established in 1997 and headquartered in Pencoed, UK, ReNeuron Group plc... Established in 1997 and headquartered in Pencoed, UK, ReNeuron Group plc focuses on the research, development, and commercialization of innovative cell-based therapies. The company is actively developing a CTX stem cell therapy candidate targeting stroke disability, which is currently at the partnering stage for distribution both within and outside China. Another significant pipeline asset is its human retinal progenitor cell therapy, now in Phase I/IIa clinical trials, designed to treat retinitis pigmentosa, a debilitating eye disease leading to blindness. Furthermore, ReNeuron is conducting pre-clinical investigations into CTX-derived exosomes, which are microscopic, information-carrying packages released by CTX cells. The firm also generates revenue through the licensing of its ReNcell products. Collaboratively, ReNeuron has partnered with University College London to explore the creation of immune cells from induced pluripotent stem cells for application in anti-cancer cell therapies.
Giá cổ phiếu
$0.00042815
Đồng bộ lần cuối: 2024-02-27
Vốn hóa thị trường
$13.55K
Thay đổi (1 ngày)
0.03%
Thay đổi (1 năm)
0.00%
Quốc gia
GB
Giao dịch ReNeuron Group plc (RENE)

Danh mục

Lịch sử giá cổ phiếu của ReNeuron Group plc (RENE)
Giá đóng cửa cao nhất: $0.00 vào 2024-02-01

Giá đóng cửa thấp nhất: $0.36 vào 2005-08-01
Lịch sử giá cổ phiếu của ReNeuron Group plc từ 2005 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2024 492.28%
2023 -66.21%
2022 -87.48%
2021 5.22%
2020 -36.63%
2019 161.49%
2018 -74.42%
2017 -25.77%
2016 -17.55%
2015 -23.54%
2014 5.79%
2013 64.85%
2012 -53.76%
2011 -27.98%
2010 4.29%
2009 128.98%
2008 -89.60%
2007 -24.17%
2006 39.08%
2005 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
$527.87 33.33%
US
$873.57 35.10%
NL
$741.32 8.41%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE